OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies
Jing Zhou, Qing Ji, Qi Li
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 146
Jing Zhou, Qing Ji, Qi Li
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 146
Showing 26-50 of 146 citing articles:
Jun, an Oncological Foe or Friend?
Zuhayr Jafri, Yue Li, Jingwen Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 555-555
Open Access
Zuhayr Jafri, Yue Li, Jingwen Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 555-555
Open Access
The role of monoclonal antibodies in the treatment of pancreatic and colon cancers
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
The roles of IDH2 and glutathione metabolism in cetuximab resistance in head and neck squamous cell carcinoma investigated by metabolomics and transcriptomics
Shousen Hu, Z D Wang, Xu Ding, et al.
Cellular Signalling (2025) Vol. 127, pp. 111620-111620
Closed Access
Shousen Hu, Z D Wang, Xu Ding, et al.
Cellular Signalling (2025) Vol. 127, pp. 111620-111620
Closed Access
Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches
Nayeralsadat Fatemi, Seyedeh Nasim Mirbahari, Sascha Tierling, et al.
Digestive Diseases and Sciences (2025)
Open Access
Nayeralsadat Fatemi, Seyedeh Nasim Mirbahari, Sascha Tierling, et al.
Digestive Diseases and Sciences (2025)
Open Access
The Use of Plant Viral Nanoparticles in Cancer Biotherapy—A Review
Mamorake Donty Komane, Prudence Ngalula Kayoka‐Kabongo, Daria A. Rutkowska
Viruses (2025) Vol. 17, Iss. 2, pp. 218-218
Open Access
Mamorake Donty Komane, Prudence Ngalula Kayoka‐Kabongo, Daria A. Rutkowska
Viruses (2025) Vol. 17, Iss. 2, pp. 218-218
Open Access
Targeting adenosine enhances immunotherapy in MSS colorectal cancer with EGFRvIII mutation
Fei Sun, Fangzhen Yao, Chunting Zeng, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010126-e010126
Open Access
Fei Sun, Fangzhen Yao, Chunting Zeng, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010126-e010126
Open Access
The interplay between gut bacteria and targeted therapies: implications for future cancer treatments
Juan He, Yu Chen, Huakan Zhao, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Juan He, Yu Chen, Huakan Zhao, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer
Federica Randisi, Gianpaolo Perletti, Emanuela Marras, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 623-623
Open Access
Federica Randisi, Gianpaolo Perletti, Emanuela Marras, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 623-623
Open Access
Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases
Junjie Kuang, Jun Li, Siwei Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Junjie Kuang, Jun Li, Siwei Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Precision medicine in colorectal cancer: genomics profiling and targeted treatment
Adi Muradi Muhar, Adrian Joshua Velaro, Arya Tjipta Prananda, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Adi Muradi Muhar, Adrian Joshua Velaro, Arya Tjipta Prananda, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Negative Hyperselection in Metastatic Colorectal Cancer for First-Line Anti-EGFR Therapy: A Narrative Review
Giuliana Ciappina, Enrica Toscano, Alessandro Ottaiano, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2216-2216
Open Access
Giuliana Ciappina, Enrica Toscano, Alessandro Ottaiano, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2216-2216
Open Access
Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access
Faecal microbiota transplantation combined with platinum-based doublet chemotherapy and tislelizumab as first-line treatment for driver-gene negative advanced non-small cell lung cancer (NSCLC): study protocol for a prospective, multicentre, single-arm exploratory trial
Yi Wei, Lanqun Qin, Xinyu Wu, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e094366-e094366
Open Access
Yi Wei, Lanqun Qin, Xinyu Wu, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e094366-e094366
Open Access
A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells
Go Okita, Kiyotaka Suenaga, Masashi Sakaguchi, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0312205-e0312205
Open Access
Go Okita, Kiyotaka Suenaga, Masashi Sakaguchi, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0312205-e0312205
Open Access
Preclinical evaluation of 64Cu-labeled cetuximab in immuno-PET for detecting sentinel lymph node metastasis in epidermal growth factor receptor-positive breast cancer
Takeshi Usui, Tomohiro Miyake, Tadashi Watabe, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Takeshi Usui, Tomohiro Miyake, Tadashi Watabe, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
An innovative approach to development of new pyrazolylquinolin-2-one hybrids as dual EGFR and BRAFV600E inhibitors
Mohamed M. Hawwas, Ahmed S. Mancy, Mohamed Ramadan, et al.
Molecular Diversity (2025)
Open Access
Mohamed M. Hawwas, Ahmed S. Mancy, Mohamed Ramadan, et al.
Molecular Diversity (2025)
Open Access
Translational Advances in Oncogene and Tumor-Suppressor Gene Research
Radoslav Stojchevski, Edward Agus Sutanto, R. Sutanto, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1008-1008
Open Access
Radoslav Stojchevski, Edward Agus Sutanto, R. Sutanto, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1008-1008
Open Access
EGFR Affibody and PEG functionalized protein nanoparticles: Sustaining targeting and macrophage evasion
Seonhye Jang, Hee‐jin Jun, Soomin Eom, et al.
International Journal of Biological Macromolecules (2025), pp. 142167-142167
Closed Access
Seonhye Jang, Hee‐jin Jun, Soomin Eom, et al.
International Journal of Biological Macromolecules (2025), pp. 142167-142167
Closed Access
Epacadostat Overcomes Cetuximab Resistance in Colorectal Cancer by Targeting IDO ‐Mediated Tryptophan Metabolism
Yawen Zhou, Qian Tao, Chu‐Bin Luo, et al.
Cancer Science (2025)
Open Access
Yawen Zhou, Qian Tao, Chu‐Bin Luo, et al.
Cancer Science (2025)
Open Access
Polymeric micelles in colon targeting
Vivek Patel, Kartik Hariharan, Arindam Halder, et al.
Elsevier eBooks (2025), pp. 171-193
Closed Access
Vivek Patel, Kartik Hariharan, Arindam Halder, et al.
Elsevier eBooks (2025), pp. 171-193
Closed Access
Anti-PD-1 combined with targeted therapy: Theory and practice in gastric and colorectal cancer
Yao Chen, Bingjun Bai, Kangkang Ying, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188775-188775
Closed Access | Times Cited: 21
Yao Chen, Bingjun Bai, Kangkang Ying, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188775-188775
Closed Access | Times Cited: 21
Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives
João Manzi, Camilla O. Hoff, Raphaella Ferreira, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3023-3023
Open Access | Times Cited: 12
João Manzi, Camilla O. Hoff, Raphaella Ferreira, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3023-3023
Open Access | Times Cited: 12
Inferring spatial transcriptomics markers from whole slide images to characterize metastasis-related spatial heterogeneity of colorectal tumors: A pilot study
Michael Fatemi, Eric Feng, Cyril Sharma, et al.
Journal of Pathology Informatics (2023) Vol. 14, pp. 100308-100308
Open Access | Times Cited: 11
Michael Fatemi, Eric Feng, Cyril Sharma, et al.
Journal of Pathology Informatics (2023) Vol. 14, pp. 100308-100308
Open Access | Times Cited: 11
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7131-7131
Open Access | Times Cited: 4
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7131-7131
Open Access | Times Cited: 4
Targeted anti-angiogenesis therapy for advanced osteosarcoma
Qiao Zhang, Yuxuan Xia, Liyuan Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Qiao Zhang, Yuxuan Xia, Liyuan Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
